Evidence map›Paper›PMID 31151435›Full record

ArticleMicrobial cell factories2019

Transglycosylation products generated by Talaromyces amestolkiae GH3 β-glucosidases: effect of hydroxytyrosol, vanillin and its glucosides on breast cancer cells.

Juan Antonio Méndez-Líter, Isabel Tundidor, Manuel Nieto-Domínguez, Beatriz Fernández de Toro, Andrés González Santana, Laura Isabel de Eugenio, Alicia Prieto, Juan Luis Asensio, Francisco Javier Cañada, Cristina Sánchez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Efficient production of hydroxysalidroside inSynthetic and systems biotechnology · 2025
    Article
  3. Article
  4. Potential Prebiotic Effects ofFoods (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Juan Antonio Méndez-LíterDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Isabel TundidorDepartment of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Manuel Nieto-DomínguezDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Beatriz Fernández de ToroDepartment of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Andrés González SantanaGlycochemistry and Molecular Recognition Group, Instituto de Química Orgánica General (IQOG-CSIC), Calle Juan de la Cierva, 3, 28006, Madrid, Spain.
Laura Isabel de EugenioDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Alicia PrietoDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Juan Luis AsensioGlycochemistry and Molecular Recognition Group, Instituto de Química Orgánica General (IQOG-CSIC), Calle Juan de la Cierva, 3, 28006, Madrid, Spain.
Francisco Javier CañadaDepartment of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Cristina SánchezDepartment of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
María Jesús MartínezDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain. mjmartinez@cib.csic.es.ORCID http://orcid.org/0000-0003-2166-1097
Centro de Investigaciones Biológicas Margarita Salas · ESInstituto de Química Orgánica General · ESUniversidad Complutense de Madrid · ES

Funding

Comunidad de Madrid S2013/MAE-2907MINECO BIO2015-68387-RMINECO RTC-2014-1777-3
6 · The paper itself

Abstract

backgroundTransglycosylation represents one of the most promising approaches for obtaining novel glycosides, and plant phenols and polyphenols are emerging as one of the best targets for creating new molecules with enhanced capacities. These compounds can be found in diet and exhibit a wide range of bioactivities, such as antioxidant, antihypertensive, antitumor, neuroprotective and anti-inflammatory, and the eco-friendly synthesis of glycosides from these molecules can be a suitable alternative for increasing their health benefits.

resultsTransglycosylation experiments were carried out using different GH3 β-glucosidases from the fungus Talaromyces amestolkiae. After a first screening with a wide variety of potential transglycosylation acceptors, mono-glucosylated derivatives of hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were detected. The reaction products were analyzed by thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry. Hydroxytyrosol and vanillyl alcohol were selected as the best options for transglycosylation optimization, with a final conversion yield of 13.8 and 19% of hydroxytyrosol and vanillin glucosides, respectively. NMR analysis confirmed the structures of these compounds. The evaluation of the biological effect of these glucosides using models of breast cancer cells, showed an enhancement in the anti-proliferative capacity of the vanillin derivative, and an improved safety profile of both glucosides.

conclusionsGH3 β-glucosidases from T. amestolkiae expressed in P. pastoris were able to transglycosylate a wide variety of acceptors. Between them, phenolic molecules like hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were the most suitable for its interesting biological properties. The glycosides of hydroxytyrosol and vanillin were tested, and they improved the biological activities of the original aglycons on breast cancer cells.

Indexed as

Breast NeoplasmsBenzaldehydesBenzyl AlcoholsCellulasesGlycosidesGlycosylationHumansHydroquinonesMCF-7 CellsPhenylethyl AlcoholSubstrate SpecificityTalaromyces3,4-dihydroxyphenylethanol4-hydroxybenzyl alcoholBenzaldehydesBenzyl AlcoholsCellulasesGlycosideshydroquinoneHydroquinonesPhenylethyl Alcoholvanillinvanillyl alcoholBreast cancer cellsGlucosidesGlycosyl hydrolasesHydroxytyrosolTransglycosylationVanillinβ-Glucosidases

Identifiers

PMID31151435
PMCPMC6544938
OpenAlexW2946914273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.